Trial Profile
British Society for Paediatric and Adolescent Rheumatology Etanercpet Cohort Study (BSPAR ECS) (Formerly British Society for Paediatric and Adolescent Rheumatology Biologic and New Drugs Register for Juvenile Idiopathic Arthritis Patients Treated with Biological Therapies (BSPAR BNDR))
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms BSPAR ECS; BSPAR ETN
- 28 Jan 2016 Accrual to date is 94% according to United Kingdom Clinical Research Network record
- 05 Dec 2015 Accrual to date is 93% according to United Kingdom Clinical Research Network record
- 25 Oct 2015 Accrual to date is 92% according to United Kingdom Clinical Research Network record